“ContextVision’s mission has long been to ensure the highest quality imaging and diagnostic confidence across modalities,” said Fredrik Palm, vice president, ContextVision. “Image quality continues to be of the outmost importance for our customers, and ContextVision is dedicated to driving innovation and development in order to enhance the clinical value of ultrasound and X-ray imaging.”
At ECR 2016, ContextVision will also participate in the poster exhibition of the European Society of Radiology’s EuroSafe Imaging radiation protection campaign. The company will exhibit research, which used ContextVision’s GOPView iRVUltra technology, identifying techniques for successfully reducing radiation dose while maintaining, if not improving, image quality.
Ad Statistics
Times Displayed: 32710
Times Visited: 865 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
To learn more about ContextVision’s imaging enhancement software or interventional radiology research, visit ContextVision at ECR 2016, March 2-6, Hall X1, Booth #505.
About ContextVision
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.
Back to HCB News
